logo

For the Inventor, By the Inventor

Encino, CA, United States of America

David Stover

USPTO Granted Patents = 11 

Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Encino, CA (US) (2021 - 2023)
  • Los Angeles, CA (US) (2024)

Company Filing History:

goldMedal9 out of 9 
 
Nammi Therapeutics, Inc.
 patents
silverMedal2 out of 2 
 
Qwixel Therapeutics LLC
 patents

Years Active: 2021-2025

Loading Chart...
11 patents (USPTO):Explore Patents
1. 12311010 - Formulated and/or co-formulated liposome compositions containing toll-like receptor('TLR') agonist prodrugs useful in the treatment of cancer and methods thereof (2025-05-27),
2. 12286403 - Formulated and/or co-formulated liposome compositions containing IDO antagonist prodrugs useful in the treatment of cancer and methods thereof (2025-04-29),
3. 12162958 - Fusion protein composition(s) comprising masked type i interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof (2024-12-10),
4. 12059470 - Formulated and/or co-formulated liposome compositions containing PD-1 antagonist prodrugs useful in the treatment of cancer and methods thereof (2024-08-13),
5. 11896646 - Formulated and/or co-formulated liposome compositions containing toll-like receptor ('TLR') agonist prodrugs useful in the treatment of cancer and methods thereof (2024-02-13),
6. 11833209 - Formulated and/or co-formulated liposome compositions containing PD-1 antagonist prodrugs useful in the treatment of cancer and methods thereof (2023-12-05),
7. 11801304 - Formulated and/or co-formulated liposome compositions containing TFGB antagonist prodrugs useful in the treatment of cancer and methods thereof (2023-10-31),
8. 11795198 - Fusion protein composition(s) comprising masked type I interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof (2023-10-24),
9. 11744874 - Formulated and/or co-formulated liposome compositions containing toll-like receptor ('TLR') agonist prodrugs useful in the treatment of cancer and methods thereof (2023-09-05),
10. 11679141 - Formulated and/or co-formulated liposome compositions containing toll-like receptor ('TLR') agonist prodrugs useful in the treatment of cancer and methods thereof (2023-06-20),
11. 11136353 - Fusion protein composition(s) comprising masked type I interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof (2021-10-05),

Title: The Innovative Journey of David Stover

Introduction: David Stover, a visionary inventor based in Encino, California, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents: David Stover's latest patents include a revolutionary smart home device that integrates artificial intelligence for enhanced security and convenience, as well as a sustainable energy solution for urban environments.

Career Highlights: With over two decades of experience in the tech industry, David Stover has a proven track record of developing cutting-edge products that have redefined the way we interact with technology. His work has been recognized with multiple awards for innovation and design.

Collaborations: Throughout his career, David Stover has collaborated with leading tech companies and research institutions to bring his ideas to life. His ability to work across disciplines and industries has led to the creation of truly innovative solutions.

Conclusion: David Stover's passion for innovation and his relentless pursuit of excellence continue to drive him to push the boundaries of what is possible in the world of technology. His work serves as an inspiration to aspiring inventors and entrepreneurs around the globe.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…